Even as more and more states report their first cases of the omicron variant, it’s still the super contagious delta variant that’s driving nearly all new COVID-
What’s more, it appears cases are once again rising after Thanksgiving.
By all accounts, the driver of current COVID-19 cases across the United States remains the delta variant of the coronavirus, not omicron. “It’s going to take a while for us to know what the impact is going to be globally for people who are infected with omicron,” Dr. Anthony Fauci, chief medical adviser to the Biden administration, said during Friday’s briefing.Dr. Mary Bassett, health commissioner for the New York State Department of Health, said her team has ramped up genetic sequencing to detect and study the omicron variant.
He explained that viruses mutate because they want to live, spreading more easily from person to person.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
South Africa COVID-19 Cases Almost Double in 24 HoursSouth Africa’s COVID-19 cases almost doubled within 24 hours, jumping from a reported 4,300 new cases on Tuesday to 8,500 new daily cases on Wednesday, according to the BBC.
Consulte Mais informação »
Europe surpasses 75 million COVID-19 cases amid spread of OmicronEurope crossed 75 million coronavirus cases on Friday, according to a Reuters tally, as the region braces for the new Omicron variant at a time when hospitals in some countries are already strained by the current surge. Over 15 countries in Europe have reported confirmed cases of the new variant that has rattled financial markets. The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID-19 infections in Europe within a few months.
Consulte Mais informação »
Glaxo’s Covid-19 Antibody Drug Found to Be Effective Against OmicronThe antibody treatment was effective against the variant in early laboratory studies, setting it apart from similar therapies that appear to work less well against the highly mutated strain.
Consulte Mais informação »
EU regulator begins real-time review of Valneva's COVID-19 shotThe European Union's (EU) drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva , weeks after the EU signed a deal with the company for supplies of the shot.
Consulte Mais informação »